PTSD At a Glance

Armin Moradi

2020-07-17

Epidemiology

  • 20s
  • 9.2%
  • 76%
  • 2-3x

Comorbidity

  • 75%
  • Anxiety, MDD, ODD, ADHD, EtOH, Borderline
  • Panic, Mood

Diagnosis

  • Hello DSM-V
  • Vs DSM-IV-TR
  • Treatment data: DSM-IV

Prevention

Psycho

  • No individual debriefing, ? group
  • Yes TF-CBT

Pharmaco

  • Benzos :(
  • Propranolol :)
  • SSRI :|

Treatment

Psycho

  • Education
  • Exposure
  • CBT

Limitations

  • x2

Pharmaco - first line

  • Fluoxetine
  • Paroxetine*
  • Sertraline
  • Venlafaxine*

Pharmaco - second line

  • mirtazapine

Pharmaco - third line

  • Antidepressants: imipramie, amitriptyline
  • Anticonvulsants: topiramate, lamotrigine, carbamazepine
  • Atypical antipsychotics

Pharmaco - adjunct

  • failed treatment with adequate antidepressant therapy: treatment-resistant PTSD
  • 2: eszopiclone for sleep, no risperidone
  • 3: quetiapine or aripiprazore

Combined

  • No dice :(
  • Small RCTs, combination therapy > pharmaco alone
  • Propranolol + trauma reactivation therapy

Symptom-specific

  • Prazocin: nightmare and sleep quality
  • Naltrexone: flashbacks
  • Fluphenazine: re-experiencing symptoms

Maintenance

  • fluoxetine and sertraline: low relapse rate over 6 months
  • paroxetine and sertraline: continued improvement over 6 to 12 months of continued SSRI therapy